Prof. Robbie Loewith from the University of Geneva, Department of Molecular Biology, has been elected as a new member of the prestigious European Molecular Biology Organization (EMBO). With this life-long EMBO Membership, he joins a group of more than 1,800 of the best researchers in Life Sciences in Europe and around the world.
Today, the EMBO announced the election of Prof. Robbie Loewith, research group leader at the Department of Molecular Biology and Deputy director of the NCCR Chemical Biology, as a new member. This year, 64 scientists from 21 different countries, five being from Switzerland, have been selected to join the EMBO community, which now exceeds 1,800 Members and Associate Members.
I am delighted to welcome the new members into our organization and look forward to working with them. An election to the EMBO Membership recognizes outstanding achievements in the life sciences. The new members will provide expertise and guidance that will help EMBO to further strengthen its initiatives.” says EMBO Director Maria Leptin.
Research and Biosketch
Prof. Robbie Loewith is an internationally renowned expert in the field of Target Of Rapamycin (TOR) signaling. His group uses chemical genetic approaches, state-of-the-art techniques in biochemistry, structure biology, and, in collaboration with groups in the NCCR Chemical Biology, chemical-biology and biophysics, to determine in yeast how the kinase activities of the two TOR Complexes, TORC1 and TORC2, are regulated downstream of signals derived from metabolites and physical properties of membranes.
Robbie J. Loewith was born in Hamilton Ontario Canada. He studied biochemistry, and Molecular Biology and Genetics at the University of Guelph before receiving his PhD with Prof. Dallan Young at the University of Calgary. He performed postdoctoral work at the University of Basel Biozentrum with Prof. Michael Hall where he discovered the two Target Of Rapamycin Complexes. Awarded an SNF professorship, he started his independent group in the department of Molecular Biology at the University of Geneva in 2005, and became a Full Professor in 2015. In 2008, he was awarded an ERC Starting grant and in 2014 an ERC Consolidator grant. Since 2010, he has been part of the NCCR Chemical Biology as a project leader. He is currently deputy Director of the NCCR Chemical Biology, Head of the educational committee for the Master’s in Chemical Biology and member of the NCCR steering committee.
Read more about Robbie Loewith’s research on his lab website.
EMBO is an international organisation of life scientists, which has more than 1800 members elected by peers. EMBO directs funding from its member states towards research fellowships, courses, workshops, conferences, and science policy initiatives, and also has a stable of journals. Administrative headquarters are in Heidelberg, Germany. More information can be found here: www.embo.org.
EMBO Membership honours distinguished scientists who have made outstanding contributions to the life sciences, including 90 Nobel Laureates who have/have held EMBO Membership. EMBO Members can actively participate in EMBO’s initiatives by serving on the organisation’s Council, committees and editorial boards, participating in the evaluation of applications for EMBO funding, acting as mentors to young scientists in our community, and advising on key activities. More information can be found here: www.embo.org/members.html.
EMBO Members are actively involved in the organization. They serve on EMBO Council, Committees and Advisory Editorial Boards of EMBO Press journals, evaluate applications for EMBO funding, and mentor early-career scientists. Collectively, they can influence the direction of the life sciences in Europe and beyond. New members are nominated and elected by the existing EMBO Membership.